Back to Results
First PageMeta Content
Medicine / Acid fast bacilli / Corynebacterineae / Antibiotic-resistant bacteria / Tuberculosis treatment / Mycobacterium / Extensively drug-resistant tuberculosis / Mycobacteria growth indicator tube / Clinical and Laboratory Standards Institute / Bacteria / Tuberculosis / Microbiology


Mycobacterium tuberculosis Complex Drug Susceptibility Testing Program
Add to Reading List

Document Date: 2014-12-24 13:25:52


Open Document

File Size: 1,06 MB

Share Result on Facebook

Company

Participating Laboratories / Cepheid / Reference Laboratory / /

Country

United States / /

/

Event

FDA Phase / /

Facility

Hospital laboratory / Laboratory Standards Institute / Laboratory Capacity Team / U.S. Centers for Disease Control and Prevention CLSI Clinical Laboratory / Laboratory Developed Tests / /

IndustryTerm

satellite clinic / educational self-assessment tool / /

MedicalCondition

S susceptible Sensititre Trek Diagnostic Systems Sensititre Susceptibility Panel STR streptomycin TB tuberculosis VersaTREK VersaTREK Myco susceptibility kit XDR / M. tuberculosis complex / XDR TB / MIC minimum inhibitory concentration MPEP Model Performance Evaluation Program MTBC Mycobacterium tuberculosis / tuberculosis / /

Organization

U.S. Department of Health and Human Services / Clinical and Laboratory Standards Institute / ETA / Health / U.S. Centers for Disease Control and Prevention CLSI Clinical Laboratory / U.S. Centers for Disease Control and Prevention / Centers for Disease Control and Prevention / /

Person

Beverly Metchock / Cortney Stafford / Mitchell Yakrus / Angela Starks / Lois Diem / /

/

Position

author / Scientist / Laboratory Capacity Team / /

Product

kanamycin / levofloxacin / pyrazinamide / ofloxacin / INH / Remington m24 / ciprofloxacin / isoniazid / rifampin / M24-A2 / /

Technology

Genotype / /

SocialTag